Biochem 6 Flashcards
krebs cycle/tricarboxylic acid/citric acid
- one substrate- acetyl CoA
- one product- CO2
- its not get a way to oxidize acetyl CoA or make ATP
only a small amount of energy available in glucose is captured in glycolysis
- complete oxidation only using the glycolytic path only generates pyruvate acid from glucose and a certain amount of free energy to make ATP
- complete oxidation of glucose (glycolysis and krebs) -> makes a lot more free energy and ATP
- amount per glucose is not the important part -> you can upregulate
- if the flux of the glycolytic pathway can be increased by 2 orders of magnitude -> doesnt matter how many ATP you can get per glucose (as long you have a good amount)
in eukaryotes, stages 2 and 3 are localized to the mitochondria
- glycolysis occurs in the cytoplasm
- citric acid cycle occurs in the mitochondrial matrix
- mitochondrial matrix has high concentration of enzymes (soluble)
- oxidative phosphorylation occurs in the inner membrane
- there are proteins/enzymes in the inner membrane -> carriers for the ETC
- succinate dehydrogenase -> enzyme participates in the krebs cycle and ETC
- proteins in the inner membrane transport protons
- matrix is proton poor compared to cytosol (proton rich)
- proton movement from the cytosol to the matrix through the ATP synthase -> synthesis of ATP
respiration: stage 2: acetyl-CoA oxidation
- krebs cycle
- generates more NADH, FADH2, and one GTP
- substrate level phosphorylation converts GDP -> GTP
- acetyl-CoA was synthesized from pyruvate
- amino acids (glutamic acid and glutamine) can also enter the krebs cycle -> important role when the cycle is serving to be the first step of gluconeogenesis
- remaining carbon atoms from carbohydrates, amino acids, and fatty acids are released during stage 2
respiration: stage 3: oxidative phosphorylation
- generates the vast majority of ATP in well oxygenated well perfused tissues during catabolism
- inner membrane
sequence of events in oxidative decarboxylation of pyruvate
- enzyme 1:
- step 1- decarboxylation of pyruvate to an active aldehyde
- step 2- oxidation of aldehyde to a carboxylic acid
- electrons reduce lipoamide and form a thioester
- enzyme 2:
- step 3- formation of acetyl-CoA (product 1)
- enzyme 3:
- step 4- reoxidation of the lipoamide cofactor
- step 5- regeneration of the oxidized FAD cofactor -> forming NADH (product 2)
- repeat
citric acid cycle: overall cycle
- acetyl-CoA is condensed with oxaloacetic acid (alpha and beta carboxylic acid)
- claisen condensation via citric synthase -> methyl group of acetyl-CoA appears as a methylene group in citric acid (the product)
- citrate is dehydrated via aconitase to the enzyme bound product cis-aconitate (cis-aconitic acid)
- cis-aconitic acid is transferred to the next enzyme -> isocitrate dehydrogenase
- isocitrate- rehydrated product of cis-aconitic acid -> its hydroxyl group is move from the beta to the alpha -> alpha hydroxycarboxylic acid
- isocitrate dehydrogenase converts isocitrate to alpha-ketoglutarate -> loss of a CO2 (first loss of a carbon) -> decarboxylation
- alpha-ketoglutarate is oxidatively decarboxylated via alpha-ketoglutarate dehydrogenase complex -> forms succinyl-CoA (identical to pyruvate oxidative decarboxylation rxn)
- production of succinate from alpha-ketoglutarate passes through high energy mixed anhydrides and thioester
- succinyl-CoA synthetase (succinyl thiokinase) -> produces GTP by substrate level phosphorylation (from high energy mixed anhydrides and thioester)
- succinate is dehydrogenated on the inner membrane by succinate dehydrogenase (falvin dependent enzyme) -> produces fumarate
- fumarate (has a double bond) is hydrated to malate via fumarate
- malic acid is dehydrogenated by malate dehydrogenase (NAD dependent) -> forms oxaloacetate
- oxaloacetate is ready to participate in another round of cycle
first half vs second half of krebs
- first half involves decarboxylation’s -> we lose 2 carbons
- second have is rehydration and dehydrations
- 2nd half is anabolic
- 2nd half is found in cancer cells
- the only decarboxylation in cancer cells during the krebs cycle is the alpha-ketoglutarate dehydrogenase step
anaplerotic reactions
- nothing is made or destroyed -> intermediates are extracted though
- oxaloacetate can be extracted for gluconeogenesis
- glutamic acid can be converted to alpha-ketogluteric acid and supplement the species in the krebs cycle
- anaplerotic rxns deplete or enrich the krebs
summary of sequence of events in the citric acid cycle
- step 1- C-C bond formation between acetate (2C) and oxaloacetate (4C) to make citrate (6C)
- step 2- isomerization via dehydration/rehydration
- steps 3-4- oxidative carboxylations to give 2 NADH
- step 5- substrate level phosphorylation to give GTP
- step 6 - dehydrogenation to have FADH2
- step 7- hydration
- step 8- dehydrogenation to give NADH
citric acid cycle: step 1: C-C bond formation by condensation of acetyl-CoA and oxaloacetate
- condensation of oxaloacetate and acetyl-CoA via citrate synthase
- acetyl-CoA- thioester (high energy) -> instead of being used to make an ATP it goes into a condensation rxn and uses the energy to drive the rxn
- huge -ΔG -> -32.2 kJ/mol
- highly thermodynamically favorable/irreversible
- pushes the entire kreb cycle in one direction
- this is the only rxn with C-C bond formation
- uses acid/base catalysis
- carbonyl of oxaloacetate is a good electrophile
- methyl of acetyl CoA is a not a good nucleophile unless activated by deprotonation
- this is the rate limiting step
- activity largely depends on oxaloacetate
- product is citrate
- regulated by substrate availability and product inhibition -> bc oxaloacetate has other fates (gluconeogenesis or making malate which is more favored)
induced fit in the citrate synthase (step 1 enzyme)
- conformational change occurs upon binding oxaloacetate
- ordered bisubstrate rxn
- avoid unnecessary hydrolysis of thioester in acetyl-CoA
- open conformation- binds oxaloacetate very well but free enzyme does not have a binding site for acetyl-CoA
- closed conformation- binding of OAA created binding for acetyl-CoA -> reactive carbanion is protected
- the idea that the enzyme cannot bind the second substrate until the first substrate is bound -> bisubstrate rxn with obligate binding order
- analog of acetyl-CoA is an uncompetitive inhibitor for oxaloacetate
- conformational change protects the product from premature hydrolysis
- enzyme hides substrates from water
- oxaloacetate binds to bottom of a site that creates an anchor for acetyl CoA to then finally enter the binding site
citric acid cyce: step 2: isomerization by dehydration/rehydration
- hydroxyl group is moved from 2 position to 1 position
- citrate is converted to isocitrate via aconitase enzyme
- small ΔG
- not favored one way or another -> more unfavorable/reversible
- product concentration kept low to pull forward rxn
- isocitrate is active product -> L-isocitrate
- elimination of H2O from citrate gives cis double bond -> lyase
- citrate (tertiary alcohol) is a poor substrate for oxidation
- isocitrate (secondary alcohol) is a good substrate for oxidation
- addition of H2O to cis-aconitate is stereospecific
iron sulfur center in aconitase
- water removal from citrate and subsequent addition to cis-aconitate are catalyzed by the iron-sulfur center -> sensitive to oxidative stress
- only make L-isocitrate (optically active) from inactive citrate
- aconitase has iron sulfur center
- holds citrate in a specific conformation to define the dehydration of citrate to form cis-aconitate
- enzyme is asymmetric and can only bind in one orientation
- citrate is a prochiral molecules -> noramlly optically inactive but replacement of either -CH2COO- groups would make the central C chiral -> active
- aconitase is stereospecific
- augstin 3 point attachment model -> if the enzyme can bind to optically inactive substrate (citrate) at at least 3 points the product will be stereospecifically defined (L-isocitrate)
- possible to induce a center of chirality by binding a optically inactive substrate at at least 3 points
citric acid cycle: step 3: oxidative decarboxylation by isocitrate dehydrogenase
- isocitrate is easily dehydrated via isocitrate dehydrogenase
- isocitrate dehydrogenase is a mitochondrial enzyme that makes use of NAD
- allosteric site for ATP -> inhibits mitochondrial enzyme
- ATP is the product of oxidative decarboxylation -> negative feedback
- oxalosuccinate is an enzyme bound intermediate -> beta keto acid -> spontaneously decarboxylate
- forms a 5 carbon dicarboxylic acid -> alpha-ketoglutarate (similar to alpha-keto acid pyruvate)
- forms NADH for ETC
- alpha-ketoglutarate is the product -> imported from glutamine or exported to glutamate -> regulation
- highly favorable and irreversible (but it is reversible in the cytosol with NADP -> cancer cells)
- some alpha-ketoglutarate is converted back to isocitrate
- cytosolic isocitrate dehydrogenase makes use of NADP -> this enzyme may run the rxn in the opposite direction in cancer cells -> produces isocitrate and then citrate -> citrate leaves into cytosol and carries out biosynthetic rxns
- catalyzes a rate limiting step -> speeds up the entire krebs in presence of ADP and Ca
citric acid cycle: step 4: final oxidative decarboxylation by alpha-ketoglutarate dehydrogenase
- alpha-ketoglutarate (5 carbon dicarboxylic acid) converted to succinyl-CoA via alpha-ketoglutarate dehydrogenase complex
- this complex is very similar to pyruvate dehydrogenase complex -> all the same cofactors
- E1 and E2 are different to accommodate different sized substrates but E3 are identical
- favorable -> irreversible
- regulated by product inhibition
- oxidative decarboxylation of an alpha-keto acid -> TPP
- last oxidative decarboxylation
- net full oxidation of all carbons of glucose after 2 turns of the cycle
- carbons not directly from glucose bc carbons lost come from oxaloacetate, not acetate
- succinyl-COA is another higher energy thioester bond
alpha-ketoacids making use of TPP
- alpha-ketoacids that are oxidatively decarboxylated used same mechanisms using TPP
- seen in pyruvate dehydrogenase complex -> acetyl-CoA
- citric acid cycle -> step 4 -> succinyl-CoA
- oxidation of isoleucine (leucine, valine) -> branched amino acids -> produces alpha-methylbutyryl-CoA
alpha-ketoglutarate dehydrogenase complex
- three enzymes
- 5 cofactors
- E1- alpha-ketoglutarate dehydrogenase (TPP)
- E2- dihydrolipoyl transsuccinylase (lipoamide, CoA)
- E3- dihydrolipoyl dehydrogenase (NAD+, FAD)
- E3 from pyruvate dehydrogenase complex is identical to E3 from alpha-ketoglutarate dehydrogenase complex
- alpha-ketoglutarate reacts with TPP -> forms hydroxyethyl-TPP complex -> forms active succinyl intermediate
- active succinyl intermediate is transferred to lipoic acid to produce succinyl hydrolipoic acid
- succinyl hydrolipoic acid reacts with CoA -> forms succinyl-CoA (thioester) and dihydrolipoic acid
- E3=E3 of pyruvate dehydrogenase
- dihydrolipoic acid is reoxidized by disulfide -> forms an internal dithiol -> reoxidized by FAD -> which is reoxidized by NAD -> produces a NADH and reoxidized lipoic acid to repeat
- long lipollysyl arm transfers intermediates from one active site to another
- this rxn is abnormally low in people suffering from beriberi (deficiency of thiamine)
- 2 different coenzymes with sulfhydryl groups participate
origin of C-atoms in CO2
- carbons from acetate are red
- all CO2 generated during the citric acid cycle is produced before succinyl-CoA is made
- in one turn of the citric acid cycle, neither of the red carbons is lost
- both CO2 molecules lost were present on the oxaloacetate used to begin the cycle
- citrate -> isocitrate -> alpha-ketoglutarate -> succinyl-CoA (6 carbons to 4 carbons)
- citrate is made from 4 carbon oxaloacetate and 2 carbons from acetyl-CoA
- the 2 carbons from acetyl-CoA are NOT the carbons released until we convert succinyl-CoA to succinate -> in this step the molecule loses it selectivity and structure
- carbons from acetyl-CoA are retained from conversion to citrate to succinyl-CoA
citric acid cycle: step 5: generation of GTP through thioester
- substrate level phosphorylation by succinyl-CoA synthetase
- succinyl-CoA synthetase- going from succinate to succinyl-CoA (reverse)
- succinyl thiokinase- going from succinyl-CoA to free succinate (forward)
- conversion of succinyl-CoA to succinate
- free thiol of succinyl-CoA comes from CoA (thiol came from the enzyme itself from glyceraldehyde-3-dehydrogenase)
- it makes a phosphoenyzme and a mixed anhydride
- succinyl-CoA reacts with inorganic phosphate and the enzyme succinyl thiokinase -> forms an enzyme bound mixed anhydride -> uses this to make a phosphohistidiene on the enzyme -> phosphohistidyl enzyme
- succinate is released (symmetrical and inactive)
- phosphohistidiene is used to phosphorylate GDP to make GTP
- sulfhydryl is not contributed by the enzyme -> rather CoA
- similar to the way thioester was used by glyceraldehyde-3-phosphate dehydrogenase and diphosphoglycerate kinase -> made a mixed anhydride
- for the enzyme diphosphoglycerate kinase direct phosphorolysis succinyl-CoA by inorganic phosphate to make ATP -> but in this rxn the enzyme succinyl thiokinase puts the phosphate onto a histidine and then onto GTP (substrate level phosphorylation)
- acyl phosphate
citric acid cycle: step 6: oxidation of an alkane to alkene by succinate dehydrogenase
- succinate converted to fumarate via succinate dehydrogenase
- succinate is optically inactive -> origin of the carbons become scrambled
- succinate dehydrogenase part of the mitochondrial inner membrane
- highly reversible (near equilibrium
- product concentration kept low to pull forward
- this enzyme is special bc its also an intermediate step in the electron transport chain -> acts as complex II in the ETC
- flavin dependent enzyme
- succinate reduced FAD - FADH2
- succinate itself becomes oxidized -> fumarate
- reduced of alkane to alkene requires FADH2
- reduction potential of carbon-hydrogen bond is too low for production of NADH
- FAD is covalently bound (unusual)
citric acid cycle: step 7: hydration across a double bond
- addition of water to fumarate (fumaric acid) to L-malate (malic acid) via fumarase
- malate is chiral (optically active)
- fumarate is optically inactive -> converted to L-malate
- somewhat similar to 3 point model of aconitase
- slightly thermodynamically favorable -> highly reversible
- product concentration kept low to pull rxn forward
- fumarase is stereospecific
- addition of water to fumarate is always trans and forms L-malate
- OH- adds to fumarate -> then H+ adds to the carbanion
- cannot distinguish between inner carbons -> so either can gain the OH-
- if you give fumarase D-malate it will attempt to make maleate (maleaic acid) -> cis
citric acid cycle: step 8: oxidation of alcohol to a ketone and regeneration of oxaloacetate by malate dehydrogenase
- L-malate is oxidized to oxaloacetate via L-malate dehydrogenase
- L-malate is capable of diffusing out of the mitochondrial membrane -> implications for gluconeogenesis
- unfavorable -> reversible
- citrate synthase has a low delta G -> favorable -> therefore this rxn is winning -> free oxaloacetate concentration is low in mitochondria -> pulls rxn forward
- final step of the krebs
- regenerates oxaloacetate for citrate synthase
- NAD reduced to NADH
- malate dehydrogenase helps overcome the impermeability of oxaloacetate to the mitochondrial membrane -> mitochondrial and cytosolic catalyze malate/oxaloacetate interconversion that are part of malate-oxaloacetate shuttle
Net result of the citric acid cycle
acetyl-CoA + 3NAD+ + FAD + GDP + Pi + 2H2O -> 2CO2 + 3NADH + FADH2 + GTP + CoA + 3H+
- net oxidation of 2 carbons to CO2 -> equivalent of 2 carbons of acetyl-CoA -> but NOT the exact same carbons
- energy captured by electron transfer to NADH and FADH2
- generates 1 GTP -> can be converted to ATP
- completion of cycle
- source of GTP (ATP), CO2, and reducing equivalents (substrates for ETC -> ATP)
CAC intermediates are amphibolic
- amphibolic- both catabolic and anabolic functions
- catabolic- oxidation of acetate to CO2
- anabolic- intermediates serve as precursors to other molecules
- depletion of intermediates for anabolic pathways creates a problem for catabolism -> slows CAC
- depletion come from biosynthesis in the cell
- beginning of an anabolic path for the cancer cell
- some intermediates can go in and out of mitochondria
- krebs cycle is amphibolic -> some rxns feed the cycle and some deplete the cycle
- glutamine is used by the mitochondrion of many cancer cells and converted to glutamate and then to alpha-ketoglutarate (alpha-ketoglutarate can leave the mitochondria)
- cancer cells rely heavily on glutamine to run the second half of the krebs cycle
- involving multiple forms of isocitrate dehydrogenase we can run the first half of the krebs cycle backwards up to citrate
- citrate can leave the mitochondria -> citrate is a powerful inhibitor of glycolysis -> especially a potent inhibitor for glyceraldehyde-3-phophsate dehydrogenase
- malic acid can go in and out of the mitochondria
- oxaloacetate leaves the mitochondria by being converted to malic acid to be used but is also used inside the mitochondria for other purposes
- oxaloacetate is the keto acid that is formed from aspartic acid
- alanine (amino acid) is formed from pyruvate (keto acid)
- many amino acids can be converted to glucose -> glucogenic amino acids
- some amino acids can only be converted to kreb cycle intermediates -> ketogenic
cataplerotic reactions
- empty the citric acid cycle
- depletion
- use of citrate in metabolism
- aspartyl aminotransferase converts oxaloacetate + alanine aspartate + pyruvate -> enzymes leak out when liver is damaged
- glutamate dehydrogenase converts alpha-ketoglutarate +NADH + H+ + NH4 glutamate + NAD+ + H2O
anaplerotic reactions
- fill the citric acid cycle
- doesnt provide the substrate acetyl-CoA -> provides intermediates
- pyruvate carboxylase is rxn that creates oxaloacetate (kreb cycle intermediate)
- amino acid breakdown
- odd-chain fatty acid breakdown
- pyruvate + CO2 + ATP + H2O -> oxaloacetate + ADP + Pi
- acetyl-CoA activates pyruvate carboxylase, makes more oxaloacetate and then permits pyruvate to be used as a source of both substrate and intermediate for krebs cycle
- intermediates in the CAC can be used in biosynthetic pathways (removed from cycle)
- must replenish intermediates in order for cycle and central metabolic path to continue
- 4-carbon intermediates are formed by carboxylation of 2-carbon precursors
- involves fixation of CO2
pyruvate carboxylase: anaplerotic reaction
- pyruvate + CO2 + ATP + H2O -> oxaloacetate + ADP + Pi
- liver and kidney
- replenish krebs
PEP carboxykinase: anaplerotic rxn
- phosphoenolpyruvate + CO2 + GDP -> oxaloacetate + GTP
- heart and skeletal muscle
- replenish krebs
PEP carboxylase: anaplerotic rxn
- phosphoenolpyruvate + CO2 -> oxaloacetate + Pi
- higher plants, yeast, and bacteria
- replenish krebs
malic enzyme: anaplerotic rxn
- pyruvate + CO2 + NAD(P)H -> malate + NAD(P)
- widely distributed in eukaryotes and bacteria
- both in mitochondria and cytosol
- involves biotin
- 3-carbon -> 4- carbon
- replenish krebs
regulation of citric acid cycle
- regulated at highly thermodynamically favorable and irreversible steps -> PDH, citrate synthase, IDH, and KDH
- activated by substrate availability
- inhibited by product accumulation
- overall products of krebs (NADH and ATP) affect all regulated enzymes
- inhibitors- NADH and ATP
- activators- NAD+, ADP and AMP
- pyruvate dehydrogenase to make acetyl-CoA -> can be phosphorylated at E1 -> ATP inhibits -> inhibits krebs
- acetyl-CoA is a potent feedback inhibitor of pyruvate dehydrogenase as well
- fatty acids dont directly inhibit pyruvate dehydrogenase but they are metabolized to acetyl-CoA -> inhibits
- citrate synthase is feedback inhibited by citrate and also inhibited by succinyl-CoA
- isocitrate dehydrogenase is very sensitive and inhibited by ATP -> stimulated by ADP -> therefore the reducing equivalents will be convert ADP to ATP -> inhibits
regulation of pyruvate dehydrogenase
- regulated by reversible phosphorylation of E1: phosphorylation -> inactive and dephosphorylation -> active
- PDH kinase and PDH phosphatase (a form of phosphoprotein phosphatase) are part of mammalian PDH complex
- kinase is activated by ATP
- high ATP -> phosphorylated PDH -> less acetyl-CoA
- low ATP -> kinase is less active and phosphatase removes phosphate from PDH -> more acetyl-CoA
- regulation of PDH is somewhat similar to regulation of glycogen synthase/glycogen phosphorylase system by protein kinase cascade and phosphoprotein phosphatase
regulation of citrate synthase
- -citrate synthase is feedback inhibited by citrate and also inhibited by succinyl-CoA
- alpha-ketoglutarate is an important branch point for amino acid metabolism
- succinyl-CoA communicates flow at this branch point to the start of cycle
regulation of isocitrate dehydrogenase
- controls citrate levels
- very sensitive and inhibited by ATP -> stimulated by ADP -> therefore the reducing equivalents will be convert ADP to ATP -> inhibits
- aconitase is reversible
- inhibition of IDH leads to accumulation of isocitrate and reverses aconitase
- accumulated citrate leaves mitochondria and inhibits phosphofructokinase in glycolysis
krebs, glycolysis, and cancer
- cancer cells accumulate succinate (from succinyl thiokinase) and fumarate (from fumarase) as a result of loss of function of fumarase and succinic dehydrogenase (mutated)
- excess succinate chemically modifies enzymes involved in DNA and histone methylation -> succinylation
- cancer cells have NADP-dependent isocitrate dehydrogenase isozymes (in cytosol) with elevated activity leading to accumulation of alpha-hydroxyglutarate (2-HG)
- inhibition of alpha-ketoglutarate-dependent oxygenases by 2-HG results in extensive epigenetic modification to DNA in cancer
- cancer cells accumulate glutamine -> convert it to alpha-ketoglutarate, malate, pyruvate, and finally lactate, which is secreted in high amount by cancer cells
isocitrate dehydrogenase in cancer cells
- cytosolic
- take alpha-ketoglutarate and reduce it to alpha-hydroxyglutarate
- NADP-dependent rxn
alpha-hydroxyglutarate
- produced from isocitrate dehydrogenase in the cytosol for cancer cells
- methylates DNA and RNA
- methylates histones
- alter the functional properties of cancer cells associated with loss of contact inhibition
- alters the extracellular matrix in cancer cells
cancer cells take up glucose and glutamine
- cancer cells can do things with malic acid that is formed from the glutamine they take up -> export it to make pyruvate and lactate
- accounts for high levels of high lactic acid production in cancer cells
warburg effect
- even though cancer cells may have a lot of O2 available -> they still tended to convert (ferment) glucose into lactate
- the glucose that is being metabolized through the glycolytic pathway up to a certain point -> pyruvate kinase
- lactate is not a product of synthesis of pyruvate by the cancer cells -> rather the lactate is a product of the malate that is carrying second part of krebs forward
- the reason the pyruvate is converted to lactate cant be derived all from glucose is that -> in the step that converts phosphoenolpyruvate to pyruvate -> many cancer cells have a M2 variant of pyruvate kinase -> sluggish
- PEP accumulates or relys of glycolysis and all the glycolytic intermediates accumulate
- PEP can be used to make the phosphoglycerate mutase that converts 3-phosphoglyerate to 2-phosphosphoglycerate
- PEP continuously converts 3PG to 2PG by donating a phosphate group to the histidine of phosphoglycerate mutase (rather than ATP)
M2 isoform
- people tried to make activators for M2 isoform of pyruvate kinase to proceed through glycolysis and make pyruvate for krebs
- cancer arnt interesting in feeding their mitochondria with glycolytic intermediates -> they want to use glycolysis to make more intermediates for biosynthetic rxns
malaria
- parasite (plasmodium falciparum) can be eliminated by red cells that have undergone structural changes as a consequence of -> ex. hemoglobin S disease of glucose-6-phosphate dehydrogenase deficiency
- plasmodium falciparum does not carryout synthesis of acetyl-CoA for krebs cycle efficiently uses pyruvate and pyruvate dehydrogenase (unlike cancer cells) -> it feeds its krebs cycle with alpha-ketoglutarate (like cancer cells) from glutamic acid and glutamine
- uses the acetly-CoA to make amino sugars
- one it has made alpha-ketoglutarate and put it in the krebs -> it will secrete malate (like cancer cells)
- runs the second half of the krebs cycle in the forward direction up to the point of malate -> exports that malate
- uses the other isoform of isocitrate dehydrogenase to run the first half of krebs backward
- second half of krebs is a dehydrogenation pathway -> makes reduced products/equivalents -> if we run the 1st half of krebs backward we need to oxidize the ETC intermediates
- NO net gain of oxidation or reduction of ETC intermediates in malarial parasites -> no significant oxidation phosphorylation (ATP)
- this is ok bc it doesnt really have mitochondria it does krebs cycle in cytosol (makes minimal ATP in mitochondrion)
- mimics the metabolic events in a mammalian cancer cells -> conversion of pyruvate to lactate and running of the krebs by feeding it with alpha-ketoglutarate
ETC overview
- intermediates have been reduced
- intermediates capture electrons for redox rxns
- generates a proton motor force -> generated by movement of electrons along the ETC
- equal distribution of proton on either side of the inner membrane is responsible for synthesis of ATP
energy from reduced fuels are used to synthesize ATP in animals
- carbohydrates, lipids, and amino acids are the main reduced fuels for the cell -> get oxidized
- electrons from reduced fuels are transferred to reduced cofactors NADH or FADH2 -> drive ETC
- generate a proton gradient -> used to make ATP
- in oxidative phosphorylation, energy from NADH and FADH2 is used to make ATP
chemiosmotic theory
- ADP + Pi -> ATP is a highly thermodynamically unfavorable
- phosphorylation of ADP is not a result of a direct rxn between ADP and some high energy phosphate carrier
- energy needed to phosphorylate ADP is provided by the flow of protons down the electrochemical gradient -> driving force
- distributed unequally
- energy released by ETC is used to transport protons against the electrochemical gradient
- captures a series of oxidations of the reduced cofactors -> provides energy to establish unequal distribution of proton across the inner membrane
chemiosmotic energy coupling requires membranes
- proton gradient needed for ATP synthesis can be stably establish across inner membrane that is impermeable to ions
- membrane must contain proteins that couple the downhill flow of electron in the electron transfer chain with the uphill flow of proton across the membrane
- membrane must contain a protein that couples the subsequent downhill of protons to the phosphorylation of ADP
- intermembrane transporters have the ability to move electrons from their reduced state to oxidized state
- vectorial protons
- movement of vectorial protons -> membrane bhor effect
- proteins of ETC that bind or release protons (chemical/scalar protons) themselves through oxidation and reduction -> stochiometric
- proteins undergo conformational changes -> allows proteins to move protons from the matrix through the intermembrane to the intermembrane space
- vectorial and scalar protons are generated as a result of the movement of the electron down the ETC -> proton gradient is used to drive the ATP synthase (dissipates gradient)
- ATP synthase is induced to undergo conformational changes that causes phosphorylation of ADP -> ATP
ATP synthase
- proton gradient is used to drive the ATP synthase
- dissipates proton gradient
- induced to undergo conformational changes in its F0 subunit -> causes phosphorylation of ADP -> ATP
structure of mitochondrion
- double membrane leads to 4 distinct compartments
- outer membrane- relatively porous membrane that allows passage of metabolites
- intermembrane space (IMS)- similar environment to cytosol and has a higher proton concentration (lower pH)
- inner membrane:
- relatively impermeable (even to protons), with proton gradient across it
- location of ETC complexes (4)
- convolution called cristae serve to increase the SA
- matrix: location of the krebs and parts of lipid amino acid metabolism (oxidation) -> lower proton concentration (higher pH)
FMN and FAD: electron funnels
- FMN and FAD can be covalently bound to proteins and act to funnel and distribute electrons to ETC
- flavins
- accept 2 electrons from carrier (NADH and NADPH) that are unstable donated single electrons
- can donate 1 electron at a time, using a semiquinone-like free radical intermediate to acceptors that can only accept single electrons -> sometimes good sometime risky
cytochromes
- all cytochromes are one electron carriers
- either in ferric or ferrous state
- contains hemes
- iron coordination porphoryin ring derivatives
- feroprotoporphyrin 9 -> in hemoglobin -> this can be oxidized or reduced in the b-type cytochrome
- a. b, or c differ by ring additions
- heme A has a long hydrophobic chain that anchors it to the membrane of the last component of the ETC (complex 4)
- heme C is associated with the c-type cytochromes -> completely soluble and not bound to any membrane
- although c-type cytochrome has a binding site on the inner membrane
- cytochrome C1 (a different type) -> we find in complex 3
- cannot diffuse through (within) membranes but it can bind
- mobile carrier bc it moves from complex to complex
iron sulfur clusters
- one electron carriers
- iron is coordinated to cysteines in the protein
- there are multiple iron sulfur centers or clusters each with a distinct arrangement of sulfur atoms coordinated to the iron
- iron and sulfur (given from cysteine) are holding the clusters together
- moving electrons to the other one electron carriers like cytochromes
- participate in some rxns in which the valency is not strict -> mixture of ferous and feric iron -> imperfect stoichiometry’s of electron movement (in general one electron carriers though)
- many iron-sulfur centers contain multiple irons -> means that the electrons that are carried can move within the centers -> not just redox intermediates -> they are truly carriers that can move electrons through proteins
coenzyme Q or ubiquinone
- ubiquinone (CoQ) is a lipid soluble conjugated dicarbonyl compound that readily accepts electrons
- 2 electron donor
- hydrophobic -> never leaves the internal bilayer of membranes -> floats within
- mobile electron carrier -> goes to complex to complex
- upon accepting 2 electrons, it picks up 2 protons to give an alcohol -> ubiquinol (CoQH2)
- mechanism acquires protons selectively from one or the other side of the inner membrane
- reoxidation of ubiquinol to ubiquinone releases the protons selectively to another side of the inner membrane
- CoQ and CoQH2 can freely diffuse in the membrane, carrying electrons with protons from one side of the membrane to another side
- CoQ pool is larger than the number of complexes in the ETC
- Coenzyme Q is a mobile electron carrier transporting electrons from complexes 1 and 2 to complex 3
- can exist in quinone form (fully oxidized), semi-quinone form (reduced by 1 electron), or quinol (hydroquinone) form (fully reduced by 2 electrons)
- there is always a ubiquinone available to participate in a redox rxn
complex 1 of ETC
- NADH dehydrogenase
- contains a flavin
- contains a lot of iron sulfur clusters
- no cytochromes
complex 2 of ETC
- succinate dehydrogenase
- from krebs cycle (only part of krebs that is membrane bound)
- iron sulfur clusters
- FAD
complex 3 of ETC
- ubiquinone: cyto
- b and c type hemes/cytochromes
- iron sulfur clusters -> rieske center -> one of the irons is coordinated by 2 histidine’s
- contains histidine and cysteine
- cytochrome c participates
complex 4 of ETC
- cytochrome oxidase
- contains 2 different kinds of a-type cytochromes
- 2 copper atoms
NADH: Ubiquinone Oxidoreductase (Complex 1)
- one of the largest macromolecular assemblies in the mammalian cell
- over 40 different polypeptide chains, encoded by both nuclear and mitochondrial genes
- NADH binding site facing the matrix side
- noncovalently bound flavin mononucleotide (FMN) accepts 2 electrons from NADH
- several iron sulfur centers pass 1e- at a time toward the ubiquinone binding site (from NADH) -> forms matrix arm
- matrix arm does electron transport
- when the electron reaches the ubiquinone binding site (bound loose) it passes to the ubiquinone one at a time -> makes a semiquinone -> then the ubiquinol (QH2)
- QH2 picks up 2 protons
- QH2 stays in the intermembrane bc its so hydrophobic
- protons are transported by proton wires (membrane bohr effect)
- transmembrane proteins- responsible of movement of vectorial protons from matrix (N) to intermembrane space (P)
- bind protons on the matrix side and release them on intermembrane space -> membrane like bhor effect
- the protons that are moved are bound and released by ionizable amino acids (protonated and deprotonated) within the component of the membrane arm to get a net transfer of a proton from one side of a membrane to another
- membrane arm move about 4 protons per 2 electrons (or 1 NADH) moved through matrix arm
- NADH + Q + 5H+ = NAD+ + QH2 + 4H+
- transmembrane proteins undergo conformational changes -> drives proton pumping mechanism
- conformational changes alter the pK values of ionizable side chains so that protons are taken up or released as electrons are transferred
energy produced by complex 1
- there is enough energy to make an ATP from the reduction of CoQ by NADH
- ADP cant bind to any of the species therefore it is not made
- there is more than enough energy captured in the movement of the protons